Clinical Trial Update: A Phase II Study of Apatinib in STS Patients [Phase 2]

View source ↗

Summary

A Phase II study of apatinib in soft tissue sarcoma has been updated; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: UNKNOWN